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Histone methylation regulates chromatin struc-
ture and transcription. The recently identified
histone demethylase lysine-specific demethy-
lase 1 (LSD1) is chemically restricted to de-
methylation of only mono- and di- but not tri-
methylated histone H3 lysine 4 (H3K4me3). We
show that the X-linked mental retardation
(XLMR) gene SMCX (JARID1C), which encodes
a JmjC-domain protein, reversed H3K4me3
to di- and mono- but not unmethylated prod-
ucts. Other SMCX family members, including
SMCY, RBP2, and PLU-1, also demethylated
H3K4me3. SMCX bound H3K9me3 via its N-ter-
minal PHD (plant homeodomain) finger, which
may help coordinate H3K4 demethylation and
H3K9 methylation in transcriptional repression.
Significantly, several XLMR-patient point muta-
tions reduced SMCX demethylase activity and
binding to H3K9me3 peptides, respectively.
Importantly, studies in zebrafish and primary
mammalian neurons demonstrated a role for
SMCX in neuronal survival and dendritic devel-
opment and a link to the demethylase activity.
Our findings thus identify a family of H3K4me3
demethylases and uncover a critical link be-
tween histone modifications and XLMR.
INTRODUCTION
Histone N-terminal tails are subject to a plethora of post-
translational modifications, including phosphorylation,
ubiquitination, acetylation, and methylation. Each modifi-
cation can affect chromatin architecture, but the total
sum of these modifications may be the ultimate determi-
nant of the chromatin state, which governs gene transcrip-Ction (Jenuwein and Allis, 2001; Strahl and Allis, 2000).
Methylation occurs on both lysine (K) and arginine (R) res-
idues. Five K residues on the tails of histones H3 and H4
(H3K4, -9, -27, -36, and H4K20) as well as K79 located
within the core of histone H3 have been shown to be sites
for methylation (Margueron et al., 2005; Zhang and
Reinberg, 2001). Lysine methylation exists in three differ-
ent states, including mono-, di-, or trimethylation, which
may bring about additional regulatory complexity. Histone
methylation has been linked to transcriptional activation
and repression, as well as DNA-damage response
(Sanders et al., 2004; Zhang and Reinberg, 2001). It has
also been implicated in heterochromatin formation, X in-
activation, genomic imprinting, and silencing of homeotic
genes, demonstrating an important role for histone meth-
ylation in multiple biological processes (Martin and Zhang,
2005). Until recently, histone methylation was considered
enzymatically irreversible. However, the recent discovery
of a large number of histone demethylases indicates that
demethylases play a central role in the regulation of his-
tone methylation dynamics (Cloos et al., 2006; Fodor
et al., 2006; Klose et al., 2006b; Metzger et al., 2005; Shi
et al., 2004; Tsukada et al., 2006; Whetstine et al., 2006;
Yamane et al., 2006).
Histone H3K4 trimethylation positively regulates tran-
scription (Liang et al., 2004; Litt et al., 2001; Noma et al.,
2001; Santos-Rosa et al., 2002; Schneider et al., 2004) in
part by recruiting chromatin-remodeling complexes
(Santos-Rosa et al., 2003; Wysocka et al., 2006). H3K4
methylation is dynamically regulated by histone methyl-
ases and the recently identified demethylase lysine-spe-
cific demethylase 1 (LSD1), whichmediates demethylation
of H3K4me1/2, but not H3K4me3, due to the inherent
chemistry (Shi et al., 2004). Given the critical role of
H3K4me3 in active transcription, it is of significant interest
to investigate whether there are demethylases that specif-
ically reverse H3K4 trimethylation.
We used a candidate approach (Whetstine et al., 2006)
to search for H3K4me3 histone demethylases, focusing
on approximately 28 human JmjC-domain-containingell 128, 1077–1088, March 23, 2007 ª2007 Elsevier Inc. 1077
proteins. In this report, we provide both in vitro and in vivo
evidence that SMCX (alias JARID1C) reverses both H3K4
tri- and dimethylation. SMCX contains the catalytic JmjC
domain, JmjN, and a C5HC2 zinc finger, as well as two
plant homeodomain (PHD) domains, a motif that binds
methyl-lysine residues (Shi et al., 2006; Wysocka et al.,
2006). Importantly, SMCX has recently been shown to
be a causal gene for X-linked mental retardation (XLMR)
(Jensen et al., 2005). XLMR is a heterogenous disease in-
volving environmental, stochastic, and/or genetic factors.
It affects 2 out of 1000 males, and the symptom ranges
from mild to severe mental retardation (Ropers and
Hamel, 2005). Although systematic mutation screenings
have identified many genes implicated in XLMR, SMCX
appears to be one of the more frequently mutated genes
in this disease (Tzschach et al., 2006). Thirteen SMCX
point mutations have been identified (Jensen et al.,
2005; Santos et al., 2006; Tzschach et al., 2006). Most
of these mutations are missense mutations, which are
located near JmjN, JmjC, the C5HC2 finger, and the
N-terminal PHD domain, but the molecular consequences
of these mutations were unclear.
SMCX is evolutionarily conserved, and in mammals, it is
a member of a subfamily of four proteins, including SMCY
(JARID1D), RBP2 (JARID1A), and PLU-1 (JARID1B) (Klose
et al., 2006a). The other family members are also asso-
ciated with important biology and human diseases. For in-
stance, SMCY was identified as a male-specific antigen
(Agulnik et al., 1994; Scott et al., 1995; Wang et al.,
1995), while RBP2 was isolated as a pRB binding protein
(Defeo-Jones et al., 1991), and its inactivation was pro-
posed to be important for pRB to promote differentiation
(Benevolenskaya et al., 2005). Analysis of the fission yeast
S. pombe homolog of RBP2, Msc1, suggested a possible
role for this protein in modulating cellular response to DNA
damage (Ahmed et al., 2004). Plu-1, on the other hand,
has a restricted expression pattern in the testis, ovary,
and transiently in the mammary gland of the pregnant fe-
male (Barrett et al., 2002) and has been shown to be upre-
gulated in breast and testis cancer, suggesting a potential
role in tumorigenesis (Lu et al., 1999). PLU-1 has also been
shown to interact with the DNA binding transcription
factors BF-1 and PAX9 and possibly function as a tran-
scriptional corepressor (Tan et al., 2003). These findings
suggest a link between this family of proteins with multiple
biological processes and human diseases.
We show that SMCX is a H3K4 trimethyl-histone de-
methylase, catalyzing demethylation of H3K4me3 to
H3K4me1, but having no effect on methylation at other ly-
sine residues, including H3K9, -27, -36, and H4K20. Con-
sistent with these observations, overexpression of SMCX
resulted in a specific reduction of H3K4me3 in cultured
cells. As expected, we found that the other human
SMCX family members were also H3K4 demethylases.
We show that one of the two PHD fingers of SMCX specif-
ically bound H3K9me3, suggesting crosstalks between
H3K4 and H3K9 methylation in transcriptional repression.
Importantly, SMCX mutations associated with XLMR1078 Cell 128, 1077–1088, March 23, 2007 ª2007 Elsevier Inccompromised the demethylase activity, as well as its abil-
ity to bind H3K9me3. These findings suggest that a reduc-
tion of SMCX demethylation function is detrimental and
may be a common cause of XLMR associated with
SMCXmutations. To gain insights into the biological con-
text in which SMCX functions that may be relevant to un-
derstanding of its role in XLMR, we investigated SMCX in
both zebrafish and mammalian neurons. In situ hybridiza-
tion revealed a developmental expression profile of SMCX
that is restricted to the zebrafish brain. Consistently, inhi-
bition of smcx resulted in significant defects in neuronal
development in zebrafish, including increased neuronal
cell death. In addition, inhibition of Smcx in primary
mammalian neurons impaired dendritic morphogenesis.
Importantly, while an RNAi-resistant wild-type SMCX
transgene restored dendritic growth in the background
of smcx knockdown, transgenes carrying point mutations,
including an XLMR-patient point mutation, that disrupt de-
methylase activity failed to effectively restore dendritic
growth, thus linking the demethylase activity to SMCX
regulation of dendritic development. Our findings thus de-
fine a family of enzymes that reverse H3K4 trimethylation
and provide novel insights into the molecular mechanisms
that underlie XLMR pathology.
RESULTS
SMCX Mediates Demethylation of Histone H3K4me3
and H3K4me2
SMCX (JARID1C) belongs to a small family of evolution-
arily conserved proteins, whose members include RBP2
(JARID1A), PLU-1 (JARID1B), and SMCY (JARID1D)
(Figure S1). The SMCX family members contain the JmjC
domain, which has been shown to be the catalytic moiety
for multiple histone demethylases (Chen et al., 2006;
Cloos et al., 2006; Klose et al., 2006b; Tsukada et al.,
2006; Whetstine et al., 2006; Yamane et al., 2006). Mem-
bers of the SMCX family also contain the JmjN domain,
which is conserved among a subset of JmjC-domain pro-
teins and has recently been shown to be important for
maintaining the structural integrity of the adjacent JmjC
domain, and therefore is critical for catalysis (Chen et al.,
2006). SMCX family members also contain a C5HC2 zinc
finger located C-terminal to the JmjC domain. Although
its function is unclear, a C2HC4 zinc finger has been
shown to be important for JHDM2A demethylase activity
(Yamane et al., 2006). All four members contain the
BRIGHT domain, which is an AT-rich domain interacting
domain (ARID). ARID domains have the capability of bind-
ing DNA in a sequence-specific and nonsequence specific
manner (Kortschak et al., 2000; Wilsker et al., 2002), sug-
gesting that SMCX and its related proteins may have sim-
ilar properties. Finally, all four members contain the PHD
domain, which has recently been shown to be a histone-
methyl-lysine binding motif (Shi et al., 2006; Wysocka
et al., 2006). Phylogenic analysis shows that SMCX,
SMCY, and RBP2 are more similar to one another than
PLU-1 (Figure S1). Importantly, the amino acids within.
Figure 1. Histone Demethylation Medi-
ated by the Full-Length SMCX
Mono-, di-, and trimethylated synthetic histone
peptide (2 mg) were incubated with SMCX (2 mg)
purified from Sf9 cells. Demethylated peptides
were detected as mass peaks with the molec-
ular weight that are 14 Da smaller than the input
peptides. Demethylated peptides are marked
with starred and shaded panels. Among the
methylated residues examined (H3K4, -9, -27,
and -36, and H4K20), SMCX removed methyl
moieties only from H3K4me2 and H3K4me3.the JmjC domain that have been shown to be critical for
cofactor binding and catalysis are conserved among all
four SMCX family members (data not shown).
To determine whether SMCX is a histone demethylase,
we isolated a full-length SMCX cDNA from HeLa cells by
RT-PCR, subcloned it into a Gateway entry vector, subse-
quently transferred it to a baculoviral expression vector,
and purified recombinant protein to near homogeneity
from insect Sf9 cells. We used a MALDI-TOF mass spec-
trometric approach to screen for demethylation using a
variety of histone peptides representing mono-, di-, and
trimethylation for four lysines on H3 and one lysine residue
on H4. As shown in Figure 1, SMCX mediated demethyla-
tion at H3K4, but not H3K9, K27, K36, or H4K20. SMCX
appeared to specifically demethylate H3K4me3 and
H3K4me2 but not H3K4me1 (Figure 1, shaded panels),
suggesting that SMCX converts H3K4 from tri- to mono-
methylated state. Consistent with these observations,
when bulk histones were used as substrates, western
blot analysis also showed SMCX-mediated demethylation
of both H3K4me3 and H3K4me2 but not mono-, di-, or
trimethylated H3K9 and H3K27 (Figure 2A). JmjC-
domain-mediated demethylation reactions require Fe(II)
and a-ketoglutarate as cofactors (Chen et al., 2006;CTsukada et al., 2006; Whetstine et al., 2006). As shown
in Figure S2, omission of a-ketoglutarate, or addition of
EDTA resulted in a significant inhibition of the demethyla-
tion reaction mediated by SMCX. Taken together, these
findings show that SMCXmediates H3K4me3/2 demethy-
lation using the same chemistry described for other JmjC-
domain-containing histone demethylases.
Demethylation by Other Members
of the SMCX Family
The finding that human SMCX is a histone demethylase
prompted us to investigate whether the other three closely
related family members, SMCY, RBP2, and PLU-1, were
histone lysine demethylases as well. Full-length cDNAs
for human SMCY and RBP2 andmouse Plu-1 were cloned
into the baculoviral vector for expression in the Sf9 insect
cells. Bulk histone proteins were incubated with purified
RBP2, SMCY, and Plu-1, respectively. As shown in Fig-
ure 2B, while SMCY demethylated H3K4me3 and
H3K4me2, PLU-1 mediated demethylation of all three
methylation states of H3K4. RBP2 had barely detectable
demethylase activity under the same assay condition
(Figure 2B). Similar results were obtained using mass
spectrometry where clear albeit low demethylase activityell 128, 1077–1088, March 23, 2007 ª2007 Elsevier Inc. 1079
was detected for SMCY and Plu-1, but RBP2 showed the
lowest detectable activity (Figure S3). It is unclear whether
low levels of activity were due to improper folding of the
recombinant proteins or additional factors are needed
for optimal demethylase activity. In summary, we have
Figure 2. Specific Demethylation of Methylated H3K4 on
Native Histone by SMCX, SMCY, Plu-1, and RBP2
(A and B) Calf thymus histones (3 mg) were incubated with 3 mg of
purified, full-length SMCX, SMCY, RBP2, and PLU-1, respectively,
and subjected to western blot analysis using antibodies that specifi-
cally recognize methylated histones. Heat-inactivated recombinant
proteins were used as controls. Reduced signals were found only for
H3K4me3 and H3K4me2 by SMCX and SMCY and for all three meth-
ylation states by Plu-1. Nonspecific signals were marked as asterisks.1080 Cell 128, 1077–1088, March 23, 2007 ª2007 Elsevier Incdemonstrated that SMCX family members are histone de-
methylases that are mainly involved in demethylation of
tri- and dimethylated H3K4.
SMCX Overexpression Antagonizes H3K4
Di- and Trimethylation In Vivo
We next investigated whether SMCX overexpression
would alter H3K4 tri- and dimethylation in vivo. SMCX
was fused to the HA epitope (HA-SMCX) and transfected
into U2OS cells. Forty-eight hours posttransfection, cells
were fixed and costained with antibodies recognizing
the HA epitope and histone methylation at various lysine
residues. As shown in Figure 3, the signals representing
H3K4me3 and H3K4me2, but not H3K4me1, were signifi-
cantly reduced in 70% of the transfected cells where
SMCX was overexpressed (panels A–I; marked by ar-
rows). Importantly, the point mutation H514A that abro-
gated the demethylase activity of SMCX eliminated the
ability of HA-SMCX to reduce H3K4me2/3 in vivo (less
than 5% of the transfected cells exhibited reduced sig-
nals) (Figure 3; panels J–R), suggesting that the reduction
of the H3K4me2/3 signals was likely due to demethylation.
Taken together, these findings provide in vivo evidence
that SMCX antagonizes tri- and dimethylation at H3K4,
likely via enzymatic demethylation.
Analysis of Mutant SMCX Proteins Associated
with XLMR
Thus far, 13 SMCX point mutations have been identified in
the XLMR patients (Jensen et al., 2005; Santos et al.,
2006; Tzschach et al., 2006). Many of these mutations
are missense mutations that are located at various parts
of the gene. As shown in Figure 4A, residue A388 is lo-
cated near the N-terminal PHD finger of SMCX (PHD1)
and is mutated to proline (A388P) in some XLMR patients
(Jensen et al., 2005). Residue F642 is located near theFigure 3. Overexpression of SMCX Resulted in Reduction of H3K4me2/3 Signals In Vivo
Expression construct carrying HA-SMCX (A–I) or amutant HA-SMCX (H514A, J–R) was transiently transfected into U2OS cells and stained by anti-HA
(green) and appropriate antibodies against methylated histones (H3K4me1, H3K4me2, or H3K4me3; red). Nucleus was counterstained by Hoechst
33342. Comparing to untransfected cells, significant decrease of K4me2 and K4me3 level was found in SMCX overexpressing cells (C and F, arrows).
The demethylation activity was completely abrogated by H514A mutation (O and R, arrows). Overexpression of neither wild-type SMCX nor SMCX
(H514A) affected the K4me1 status (C and L, arrows)..
Figure 4. Histone Demethylation Activity of Mutant SMCXs Associated with X-Linked Mental Retardation (XLMR)
(A) Schematic representation of mutated amino acids of SMCX associated with XLMR that were analyzed in this study. A388P and F642L are located
close to the N-terminal PHD finger and JmjC domain, respectively. L731F and Y751C are located within the C5HC2-type zinc finger motif C-terminal
to the JmjC domain. H514A (denoted with an asterisk) is enzymatically inactive because histidine 514 is predicted to be critical for folding Fe(II).
(B) Histone-demethylation activity of themutants was examined byMALDI-TOFmass spectrometry. The relative activity was calculated from the ratio
of the demethylated peptide to the input uncatalyzed peptide from multiple experiments.catalytic JmjC domain, while L731 and Y751 are located
within the C5HC2 zinc finger adjacent to the JmjC domain
(Figure 4A). We introduced these mutations (A338P,
F642L, L731F, and Y751C) into SMCX. These mutants
were expressed equally well as the wild-type protein in
Sf9 cells (Figure S4). We carried out demethylation reac-
tions with both wild-type and mutant SMCX proteins and
found that these mutations reduced SMCX demethylase
activity ranging from 30%–70% of that of the wild-type
enzyme (Figure 4B). Similar results were obtained using
bulk histones as substrates (data not shown), suggesting
that a compromised demethylase activity of SMCX may
be an important and common mechanism that underlies
XLMR pathology.
PHD domains have recently been shown to be a protein
module that can bindmethylated lysine residues (Shi et al.,
2006; Wysocka et al., 2006). We asked whether the PHD
domains of SMCX bound methylated lysines and whether
A388Pmutation might compromise binding because of itsCclose proximity to PHD1 (Figure 4A). The two PHD do-
mains of SMCX were subcloned into GST vector, and
the fusion proteins were purified from bacteria and incu-
bated with biotinylated histone H3 peptides that are meth-
ylated at various lysine residues. As shown in Figure 5A,
PHD1 but not PHD2 of SMCX showed preferential binding
to histone H3K9me3. Importantly, A388P reduced PHD1
binding to H3K9me3 by60%, and a representative result
is shown in Figure 5B. These findings suggest that PHD1
may connect SMCX to H3K9 methylation and the patient
A388P mutation potentially compromises this communi-
cation. Taken together, these findings suggest that
A388P mutation affects both chromatin association and
enzymatic activity.
SMCX Plays a Role in Neuronal Survival
and Dendrite Development
To address the biological role of SMCX that may be
relevant to our understanding of XLMR, we undertookell 128, 1077–1088, March 23, 2007 ª2007 Elsevier Inc. 1081
Figure 5. Recognition of H3K9me3 by a PHD Finger of SMCX
(A) Histone-peptide binding assay. Two PHD fingers of SMCX, referred as PHD1 and PHD2, were fused to GST and purified from bacteria. Biotiny-
lated histone peptides shown in a panel were incubated with purified PHD fingers, and pulled down by streptavidin agarose. After washing, the bound
GST fusion proteins were visualized by western blot analysis using anti-GST antibody. Among the differently methylated histone peptides that we
tested, only H3K9me3 peptide bound PHD1. No detectable binding was found for PHD2.
(B) A388P mutation associated with X-linked mental retardation affects PHD1 binding to H3K9me3. GST-fused wild-type and mutant PHD1 carrying
A388P were incubated with H3K9me3 peptide and washed four times, and the bound fractions were analyzed by western blot analysis.analysis of smcx in zebrafish development. We first
analyzed the developmental expression pattern of the
zebrafish smcx homolog (XM_704687) by RNA in situ
hybridization. We found smcx transcripts at all stages of
zebrafish embryogenesis (Figure 6A). The ubiquitously
expressed smcx transcripts detected at 2 hr postfertiliza-
tion (hpf, Figure 6A; panel a) are likely to be maternal
transcripts, since there is no embryonic transcription at
this stage of development. During somitogenesis (12 hr,
Figure 6A; panel b), smcx appeared to be ubiquitously ex-
pressed, with slightly stronger signal in anterior regions
(future head) than in other parts of the embryo. Starting
at the postsomitogenesis stage (24 hr), smcx was de-
tected mainly in the brain (Figure 6A; panel c), while the
neural tube and some muscle tissue were also weakly
stained (Figure 6A; panel c, arrows and arrow heads,
respectively). After 36 hr, smcx staining became entirely
restricted to the head region (Figure 6A; panels d–f). Im-
portantly, the sense probes did not yield any signals at
all the corresponding stages tested (Figure 6A; panels
g–l), indicating that the in situ signals (panels a–f) are spe-
cific to smcx. In sum, the RNA in situ results suggested
that the smcx transcript was present throughout fish em-
bryogenesis, with ubiquitous expression during early
stages and exclusive expression in the head 36 hpf. We
next analyzed Smcx function in development by using
two independent morpholinos (MO) targeting smcx. As
shown in Figure 6B, both smcx MOs, but not a control
morpholino, resulted in neuronal developmental defects,1082 Cell 128, 1077–1088, March 23, 2007 ª2007 Elsevier Inc.including brain-patterning defects as well as significant
neuronal cell death as shown by acridine orange positive
signals. This suggests that fish Smcx plays an important
role in neuronal survival, consistent with its brain-specific
expression during development.
To examine whether the prosurvival role of Smcx is cell
autonomous, we transplanted a small population of MO-
treated cells into wild-type embryos and tracked the fate
of the transplanted cells. Green and red cells, which had
been treated by control MO and smcx MO respectively,
were collected from individual 4 hpf embryos and mixed,
then injected into another uninjected embryo at 5 hpf. As
shown in Figure 6C, most red signal (smcx MO) in the
head and neural tube appeared as tiny punctate spots,
likely to be extracellular aggregates of dextran dye left
over from degenerated cells. In contrast, green signal
(control MO) stained larger neural cell bodies, many of
which appear to have axons or dendrites. Furthermore, la-
beled cells, which had developed to other tissue lineages,
such as skeletal muscle fibers, stained similarly for both
green and red dyes. These data suggest that Smcx func-
tions cell autonomously and is specifically required for
neuronal cell survival and probably function.
We next characterized Smcx function in mammalian
neurons. Abnormalities of neuronal morphology, and in
particular of dendritic development, have been reported
in brains of mental retardation, including X-linked mental
retardation (Fiala et al., 2002; Ropers and Hamel, 2005).
We therefore examined the role of smcx in neuronal
Figure 6. Brain-Specific Expression and a Role for Smcx in Neuronal Survival during Zebrafish Development
(A) RNA in situ hybridization of whole-mount zebrafish embryos. In (a–f), antisense smcx RNA probe hybridized with embryos at the time points
indicated. Arrows point to the neural tube, and arrowheads indicate muscles that were weakly stained. In (g–l), or the control, sense smcx probe
hybridized with embryos of the same developmental stages.
(B) Smcx is required for proper neuronal development and survival. Zebrafish embryos injected with two independent antisense morpholinos (MO
1 and 2) to smcx show developmental delay and have abnormal brain patterning (black arrowheads) at 24 hr postfertilization (hpf) compared with
embryos injected with a control morpholino. At 48 hpf, knockdown embryos showmoderate ventral curvature of the tail. Acridine orange (AO) staining
at 30 hpf reveals dramatic cell death throughout the brain (white arrowheads) and neural tube (white arrows) in knockdown embryos.
(C) Transplantation of MO-treated cells to wild-type embryos. Live cell bodies labeled with green dye in the head of most morpholino-treated cells are
visible, and often long neuronal processes can be observed (b). Most smcxMO-treated cells with red dye formed small diffuse spots, likely to be dead
cell aggregates (c). Bright field view is shown in (a).morphogenesis. Granule neurons of the rodent cerebellar
cortex represent an excellent model system for the study
of axonal and dendritic development (Gaudilliere et al.,
2004; Konishi et al., 2004). To determine the function of
endogenous Smcx in rodent neuronal morphogenesis,
we used a plasmid-based method of RNAi (Sui et al.,
2002) to induce the knockdown of Smcx in primary gran-
ule neurons cultured from postnatal day 6 rat (P6) pups.
We used two plasmids encoding hairpin RNAs targeting
two distinct regions of Smcx (U6/smcxA and U6/smcxB).
Expression of these two hairpin RNAs led to efficient
knockdown of Smcx (data not shown). We transfected
P6 granule neurons with the U6/smcxA, U6/smcxB, or
control U6 RNAi plasmid encoding scrambled hairpin
RNAs. Smcx RNAi did not reduce cell survival in primary
granule neurons (Figure S5A). By contrast, we found that
knockdown of Smcx led to a significant reduction in den-
dritic length (Figures 7A and 7B), suggesting a requirement
for Smcx in dendritic morphogenesis. To rule out the
possibility that the Smcx knockdown-induced dendritic
phenotype is a manifestation of cell death, we induced
Smcx RNAi in primary granule neurons, in which we also
expressed the antiapoptotic protein Bcl-xl (Gaudilliere
et al., 2004). We found that Smcx knockdown significantlyCreduced dendritic length even in the presence of Bcl-xl
(Figure S5B). Importantly, Smcx knockdown did not
appear to reduce the length of axons (Figure S5C). Taken
together, these experiments suggest that Smcx knock-
down impairs dendritic development independently of
a potential effect of SMCX on cell survival.
To rule out the possibility that Smcx knockdown impairs
dendritic development as a result of nonspecific activation
of the RNAi machinery or off-target effects of Smcx RNAi,
we performed a rescue experiment. We expressed a wild-
type human SMCX protein encoded by cDNA designed to
be RNAi resistant in the background of Smcx RNAi
(SMCX-Res, data not shown). We found that expression
of SMCX-Res in primary neurons significantly increased
dendritic length in the background of Smcx RNAi, thus
reversing the Smcx knockdown-induced dendritic loss
(Figure 7C). Importantly, SMCX-Res proteins containing
point mutations that compromise the demethylase activity
(H514A), including a patient-linked mutation (F642L),
failed to effectively increase dendritic length in the back-
ground of Smcx knockdown (Figure 7C). As controls,
RNA-resistant WT, H514A, and F642L SMCX were ex-
pressed at comparable levels in 293T cells as well as cer-
ebellar granule neurons (Figure S6). Collectively, theseell 128, 1077–1088, March 23, 2007 ª2007 Elsevier Inc. 1083
Figure 7. Smcx Is Required for Dendritic Development in Rat Cerebellar Granule Neuron
(A) Representative images of primary cultured rat cerebellar granule neurons, which were cotransfected with the U6/scramble, U6/smcxA, or
U6/smcxB shRNA plasmid and a GFP expression vector and subjected to immunocytochemistry with a GFP antibody. Arrows and arrowheads
indicate dendrites and axons, respectively. Scale bar denotes 50 mm.
(B) Analysis of dendritic length of neurons transfected in (A) shows that knockdown of Smcx led to a significant decrease in total dendritic length with
two different RNA hairpins (p < 0.0001; ANOVA followed by Bonferonni-Dunn posthoc test, 160 neurons measured). Data presented as mean ± SEM.
(C) SMCX-dependent dendritic morphogenesis is linked to SMCX demethylase activity. Primary granule neurons were transfected with U6/scramble
or U6/smcx B RNAi plasmid, together with a control expression vector or an expression plasmid encoding the RNAi-resistant human SMCX protein
(WT Res) or point mutants that disrupt demethylase activity (H514A Res and F642L Res). Dendritic length was significantly reduced in Smcx knock-
down neurons as compared to U6/scramble-transfected neurons (p < 0.0001; ANOVA followed by Bonferonni-Dunn posthoc test). Dendritic length
was significantly increased in neurons expressing WT Res SMCX, but not in H514A Res- or F642L Res-expressing neurons, in the background of
Smcx RNAi, as compared to Smcx RNAi alone (p < 0.0041; ANOVA followed by Bonferonni-Dunn posthoc test). Total number of neurons measured
was 265. Data presented as mean ± SEM.results indicate that Smcx RNAi triggers dendritic loss via
specific knockdown of Smcx and that the demethylase
activity of SMCX plays an important role in SMCX-depen-
dent dendritic morphogenesis.
DISCUSSION
The recent discovery of LSD1, which mediates demethy-
lation of only mono- and dimethylated histone H3K4,
raised the question of whether H3K4 trimethylation is1084 Cell 128, 1077–1088, March 23, 2007 ª2007 Elsevier Inc.also reversible by enzymes. This was an important ques-
tion since H3K4 trimethylation is intimately linked to active
transcription. The finding of the SMCX/JARID1C family of
demethylases that reverse H3K4 trimethylation has filled
this gap and uncovered the highly dynamic nature of
H3K4methylation. Importantly, we have also provided ev-
idence that revealed themolecular basis for the SMCX de-
fects associated with X-linked mental retardation (XLMR)
as well as a biological role for SMCX in neuronal survival
and dendritic development, which may be relevant to
understanding XLMR. Collectively, our findings have
provided significant new insights into XLMR by linking
aberrant histone methylation to this disease.
H3K4 Methylation Regulation
At least eight histone methyltransferases have been found
to mediate H3K4 methylation. Until now, LSD1 was the
only H3K4 demethylase, and its enzymatic function is
chemically restricted to the reversal of only mono- and
dimethylated H3K4 (Shi et al., 2004). This study has iden-
tified four additional H3K4 demethylases and demon-
strated that, together with LSD1, these five enzymes can
reverse all three methylation states of H3K4. It also raises
the possibility of a functional collaboration between LSD1
and the SMCX family of H3K4 trimethyl demethylases in
the regulation of H3K4 methylation.
Previous studies of the JMJD2 subfamily of histone
demethylases identified differential activities among the
members toward different methylation states of H3K9.
For instance, while JMJD2A mainly demethylates
H3K9me3 to H3K9me2, JMJD2D is capable of demethy-
lating H3K9me3 to H3K9me1 (Whetstine et al., 2006).
This is likely to be due to the fact that these enzymes
have differential capabilities of recognizing different num-
bers of methyl groups, a hypothesis that is supported
by the identification of a methyl-group binding pocket
within the catalytic center of these enzymes (Chen et al.,
2006). The SMCX family of H3K4 demethylases also ap-
pears to have differential methyl-group specificities. While
SMCX catalyzed H3K4me3 to H3K4me1, Plu-1 reversed
H3K4me3 to unmethylated product, which further sup-
ports the hypothesis that demethylases may provide
a fine-tuning mechanism for histone methylation regula-
tion (Whetstine et al., 2006).
SMCX and XLMR
An important insight that this study has provided is the link
between histone methylation and XLMR. Until this study,
the molecular basis for XLMR pathology associated with
SMCX mutations was unknown. The finding that SMCX
mutations compromised the demethylase activity sug-
gests that XLMR may be in part caused by aberrant his-
tone methylation as a result of mutations of the demethy-
lase SMCX. The finding that the N-terminal PHD finger of
SMCX specifically recognizes H3K9me3 is interesting,
particularly in light of the fact that the A338P mutation
compromised this interaction, which suggests the func-
tional importance of binding of SMCX to H3K9me3. We
speculate that this interaction may help direct SMCX to
and/or stabilize SMCX at its target genomic locales, and
the PHD domain may provide a means of a functional
crosstalk between SMCX and H3K9 trimethylation in the
establishment of a repressive chromatin environment. A
similar observation has beenmade for JMJD2A, which de-
methylates H3K9me3 and H3K36me3 (Klose et al., 2006b;
Whetstine et al., 2006), but its double Tudor domain binds
methylated H3K4 (Huang et al., 2006). Therefore, cross-
talks among different modifications may be a commonCmechanism for histone-modifying enzymes to mount a
coordinated regulation of chromatin structure and tran-
scription.
Many genes have been identified to be involved in
XLMR (Chelly and Mandel, 2001; Ropers, 2006; Ropers
and Hamel, 2005). A subset of these genes seem to be in-
volved in nuclear functions, which include DNA binding
transcription factors such as the homeobox and zinc
finger proteins ARX and ZNF41 as well as chromatin-
remodeling proteins such as MeCP2 and SMCX. A num-
ber of kinases have also been implicated in XLMR, in-
cluding RSK2 and STK9/CDK5L as well as regulators of
the rhoGTPases (Ropers and Hamel, 2005). It is unclear
whether the kinases and transcriptional regulators associ-
ated with XLMR are components of the same regulatory
pathway. It is interesting to note that in addition to
SMCX, PHF8, which is a JmjC-domain protein and a
histone-demethylase candidate, is implicated in XLMR,
suggesting possible functional interactions between these
histone demethylases. Lastly, MeCP2, which is a methyl-
CpG binding protein, is also an XLMR gene (Ropers and
Hamel, 2005), suggesting possible interactions between
histone and DNA methylation in XLMR.
The biological processes regulated by SMCX were un-
known and may help shed light on mechanisms by which
a defective SMCX causes XLMR. We found expression of
the zebrafish smcx homolog during development to be
largely restricted to the brain (Figure 6A). Consistent with
this tissue-specific expression pattern, the zebrafish ex-
periments identified a role for Smcx in neuronal survival
(Figure 6B), suggesting that increased neuronal cell death
may be associated with XLMR. The neuronal phenotypes
are most likely due to smcx knockdown because the two
independent smcxmorpholinos with nonoverlapping tran-
script targets yielded the same phenotypes. These two
morpholinos are designed specifically for smcx and bear
no sequence similarity to other members of the jarid1
family or JmjC-domain histone demethylases in general.
Furthermore, several morpholinos designed for other
zebrafish smcx family members resulted in phenotypes
that are distinct from those of the smcx morpholinos-
treated animals (not shown).
The identification of a role for Smcx in dendritic devel-
opment is of particular interest (Figures 7A–7C) since ab-
normalities of dendritic spines, which are specialized
postsynaptic regions of dendrites in distinct populations
of neurons, are found in the brains of mental-retardation
patients (Govek et al., 2004). The absence of a cell-
survival phenotype upon Smcx RNAi in primary mamma-
lian cerebellar granule neurons (Figure S5), as compared
to Smcx’s prosurvival function revealed in the zebrafish
nervous system, could be due to the differing levels of
Smcx knockdown. Alternatively, it could be due to distinct
model systems and processes (neural development ver-
sus postmitotic neuronal morphogenesis), suggesting
that SMCX may be a versatile epigenetic modifier that
influences diverse biological functions in neurons. The
ability of an RNAi-resistant human SMCX transgene toell 128, 1077–1088, March 23, 2007 ª2007 Elsevier Inc. 1085
rescue the Smcx knockdown-induced dendritic pheno-
type indicates that the observed phenotype is the result
of specific Smcx knockdown rather than potential off-
target effects of RNAi (Figure 7C). Importantly, the com-
promised ability of the catalytically impaired SMCX
(including a patient-linked XLMR point mutation) to rescue
the dendritic phenotype provides a link between the de-
methylase activity and the regulation of dendritic develop-
ment by SMCX (Figure 7C). Overexpression of wild-type
SMCX did not appear to affect dendrite length, supporting
the idea that the loss of SMCX function is relevant to neu-
ronal dysfunction (Figure S5D). In future studies, it will be
important to determine SMCX function in the later phases
of dendritic development in the mammalian brain includ-
ing those that are intimately linked with postsynaptic den-
dritic morphogenesis.
In summary, we have identified a new family of histone
demethylases with specificity toward tri- and dimethy-
lated H3K4. Importantly, we have shown that XLMR-
patient point mutations compromised the demethylase
activity of SMCX, thus providing new insights into mecha-
nisms that underlie XLMR. Furthermore, the finding of
SMCX in neuronal survival and dendritic development
with a potential link to the demethylase activity of SMCX
provides a biological framework for XLMR. Lastly, since
other members of the SMCX family have been implicated
in differentiation and tumorigenesis, the identification of
these proteins as histone demethylases suggests that
misregulation of H3K4 methylation may impact multiple
biological processes, resulting in human pathological con-
ditions including XLMR and cancer.
EXPERIMENTAL PROCEDURES
Peptides and Antibodies
Biotinylated histone peptides were purchased from AnaSpec. Anti-
bodies (Ab) that recognize different histone modifications were
purchased from Upstate Group, Inc., including anti-H3K4me1 Ab
(07-436), anti-H3K4me2 (07-427), anti-H3K4me3 Ab (07-473), anti-
H3K9me1 (07-450), anti-H3K9me2 (07-441), anti-H3K9me3 (07-442),
anti-H3K27me1 (07-448), anti-H3K27me2 (07-452), anti-H3-K27me3
(07-449), and anti-panH3 (06-775).
Expression Plasmids
SMCX, SMCY, and RBP2 were PCR amplified from cDNA libraries
(HeLa, brain, lung, and testis) using Phusion polymerase (Finnen-
zymes) and cloned into the Gateway Entry System (Invitrogen).
Full-length cDNA of mouse Plu-1 (MGC: 61207) was purchased from
Invitrogen. A fully sequenced cDNA, as well as the SMCX mutants,
A388P, F642L, L731F, Y751C, and H514A generated by PCR, were
transferred into additional Gateway HA-tag and FLAG-baculoviral
expression vectors. The SMCX-PHD1 and PHD2 were cloned into
pGEX4T-1 (Amersham) for expression as GST fusion proteins in
bacteria.
Purification of FLAG-SMCX and Demethylation Reactions
The FLAG-tagged proteins were expressed in Sf9 cells using BAC-N-
BLUE baculoviral expression system (Invitrogen). Cells were lysed
in 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% NP-40, 0.2% Triton
X-100, 1mMDTT, 1mMPMSF, andProtease InhibitorCocktail (Roche).
Recombinant proteins were immobilized on FLAG M2 affinity gel
(Sigma), washedwith bufferW (20mMTris-HCl [pH 7.5], 150mMNaCl,1086 Cell 128, 1077–1088, March 23, 2007 ª2007 Elsevier Inc.8.0% glycerol, 1 mM DTT, 0.01% NP40), and eluted in buffer W con-
taining 100 mg/ml of 3x FLAG peptide (Sigma). Purified proteins were
incubated with 2 mg of histone peptides or 3 mg of calf type II-A histone
(Sigma) in the DeMTase reaction buffer (20 mM Tris-HCl [pH7.5],
150 mM NaCl, 50 mM [NH4]2Fe[SO4]2, 1 mM a-ketoglutarate, and 2 mM
ascorbic acid) for 2–5 hr at 37C. A total of 2–7.5 mg of full-length
SMCX were added to the reactions. The reactions were inhibited by
500 mM EDTA.
MALDI-TOF Mass Spectrometry
One microliter of the 50 ml demethylation reaction mixture was de-
salted through a C18 ZipTip (Millipore). The ZipTip was activated,
equilibrated, and loaded as previously described by Shi et al. (2004).
The bound material was then eluted with 10 mg/ml a-cyano-4-
hydroxycinnamic acid MALDI matrix in 70% acetonitrile/0.1% TFA
before being spotted and cocrystallized. The samples were analyzed
by a MALDI-TOF mass spectrometer.
Immunofluorescence Microscopy
U2OS cells were plated on coverslips in 24-well dishes (5.03 105 cells/
well), and expression plasmids carrying HA-SMCX or HA-SMCX
H514A were transfected with Lipofectamine 2000 (Invitrogen) accord-
ing to the manufacturer’s instructions. Forty-eight hours later, cells
were fixed with 4% paraformaldehyde, permeabilized, and blocked
with 10% fetal bovine serum (FBS). The coverslips were incubated
for 3 hr at room temperature with the appropriate primary antibodies,
washed, and incubated with the corresponding secondary antibodies
for 1 hr at room temperature. The coverslips were then washed,
mounted with Vectashield (Vector Laboratories), and analyzed by
a fluorescencemicroscopy (Nikon E600) using a 60x objective. Images
were acquired and processed with Openlab 3.1.5 software. Primary
antibodies were used at the following dilutions: 1:1,000 anti-HA
(Covance monoclonal HA.11), 1:1,000 anti-H3K4me1 (Upstate 07-
436), 1:3,000 anti-H3K4me2 (Upstate 07-030), and 1:25,000 anti-
H3K4me3 (Upstate 07-473). Alexa 594-conjgated donkey-anti-rabbit
and Alexa 488-conjugated goat-anti-mouse secondary antibodies
(Molecular probes) were used at 1:500. Hoechst 33342 was used
with all nuclear staining.
Histone Peptide Binding Assay
GST-fused PHD1 and PHD2, which correspond to 261–414 and 1146–
1267 amino acids, respectively, were expressed in E. coli strain JM109
and purified by glutathione-affinity resin (Amersham). Five micrograms
of purified proteins were incubated with 0.2 mg of biotinylated histone
peptide in 100 ml of the binding buffer (50mMTris-HCl [pH7.5], 150mM
NaCl, 0.05%NP-40, 0.3 mg/ml BSA) overnight at 4C. Protein-peptide
complexes were pulled down with streptavidin beads (Upstate),
washed five times, and subjected to western blot analysis using anti-
GST antibody (B-14, Santa Cruz, CA).
In Situ Hybridization
Whole-mount zebrafish embryo in situ hybridizations using smcx
digoxigenin-labeled antisense and sense RNA probes were carried
out following the method described previously (Chan et al., 2001).
Knockdown of Zebrafish smcx Homolog
and Phenotypic Analysis
Knockdown of zebrafish smcx was performed by injection of 2 nl of
a stock concentration of 250 mM antisense morpholinos (Gene-Tools,
LLC) into one-cell stage zebrafish embryos using a gas-driven micro-
injector (Medical Systems Corp.). The morpholino sequences used
were 50-CAAACTCCTCCCCTACATCCATCAT-30 covering transcript
bases 3 to +22 of translated sequence, and 50-TGAGTTCTTCTT
ATTCTTCGGTGAC-30, covering 46 to 22 of translated sequence
or a control morpholino of the sequence 50-CCTCTTACCTCAGTTA
CAATTTATA-30. For in vivo detection of cell death, live 30-hr-old em-
bryos were incubated in 2 mg/ml acridine orange (Sigma) in embryo
media in the dark for 30 min and washed three times in fresh embryo
media, and fluorescence was observed under 488 nm wavelength ex-
citation. Cell-transplantation experiments were performed essentially
as described (Yin and Solnica-Krezel, 2006). Briefly, control MO and
smcxMOwere coinjected with green and red fluorescent 10 kDa dex-
trans, respectively, into one-cell stage wild-type embryos, and the em-
bryos were cultured to the blastula stage where cells are still pluripo-
tent (4 hpf). We collected the green (control) and red (smcx MO) cells
from individual embryos and mixed them; then, we injected 20–40
cells of the mixture into another previously uninjected wild-type em-
bryo at a slightly later stage (5 hpf). The MO-treated cell fates were
tracked using an epifluorescence microscope at 30 hpf.
Primary Granule Neuron Transfection
and Immunocytochemistry
Primary cerebellar granule neurons were prepared from P6 Long
Evans rat pups as described (Konishi et al., 2002). Transfections
were performed using amodified calcium phosphate method 8 hr after
plating (Konishi et al., 2002). Neurons were kept in medium supple-
mented with 10% calf serum and KCl (25 mM). To prevent glial prolif-
eration, neurons were treated with 10 mM cytosine arabinofuranoside
(AraC). A GFP expression plasmid was cotransfected in all experi-
ments to reveal neuronal morphology. Cells were fixed 4 days after
plating and subjected to immunocytochemistry with antibodies di-
rected to GFP (Molecular Probes) and stained with the DNA binding
dye bisbenzimide (Hoechst 33258).
Morphological Analysis of Cerebellar Granule Neurons
To study dendritic and axonal morphology of granule neurons in pri-
mary cultures, individual images were captured randomly on a Nikon
eclipse TE2000U epifluorescence microscope using a digital CCD
camera (Diagnostic Instruments). Images were imported into the
Spot Imaging Software (Diagnostic Instruments), and length of neurites
was analyzed by tracing. Total dendrite length refers to the length of all
dendrites and branches of a given neuron added together. The same
definition was used for axonal morphometry.
Supplemental Data
Supplemental Data include six figures and can be found with this
article online at http://www.cell.com/cgi/content/full/128/6/1077/
DC1/.
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